Oblastní nemocnice Kladno, a.s.
- Address
- lock Available on a paid plan
Oblastní nemocnice Kladno, a.s.
Oblastní nemocnice Kladno is a clinical research facility in the Czech Republic actively participating in advanced therapeutic studies for inflammatory bowel diseases. The center demonstrates expertise in evaluating novel biologic therapies and their impact on complex gastrointestinal conditions requiring specialized medical management.
- Crohn's Disease treatment and management research
- Biologic therapy evaluation and subcutaneous drug delivery systems
- Endoscopic assessment and clinical remission monitoring
The facility's research focus includes Phase 3 clinical trials investigating guselkumab subcutaneous induction therapy for patients with moderately to severely active Crohn's Disease. Their participation in the GRAVITI study reflects their commitment to advancing treatment options for inflammatory bowel disease patients, with particular emphasis on achieving clinical remission and endoscopic response through innovative immunological interventions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Oblastní nemocnice Kladno, a.s.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Evolocumab on Cardiovascular Outcomes in High-Risk Patients Without Prior Myocardial Infarction or Stroke | Amgen Inc. | Phase III | Not Recruiting | May 2019 | Jul 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Evolocumab | 1 | Unknown | 2019-05-24 | 2019-05-24 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.